Neuroendocrine tumors from gastro-pancreatic origin (GEP-NET) can be responsible for
liver metastases. Such metastases can be the dominant part of the disease as well due to …

Pancreatic neuroendocrine tumors (PNETs) are rare and represent a heterogeneous
disease. PNET can be functioning or non-functioning with different clinical presentations and …

The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations
for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland …

Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be
associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical …

Simple Summary Neuroendocrine tumors (NET) are rare tumors, with long-term survival
even for patients with liver metastases. Transarterial chemoembolization (TACE) is one of …

Interventional radiology plays an important role in the management of patients with
neuroendocrine tumor liver metastasis (NELM). Transarterial embolization (TAE) …

Purpose To investigate whether whole-liver enhancing tumor burden [ETB] can serve as an
imaging biomarker and help predict survival better than World Health Organization (WHO) …

The management of patients with well-differentiated neuroendocrine tumors (NET) and non-
resectable liver metastases is challenging. Liver-directed transarterial embolization (TAE) …

Objective To evaluate the efficacy and outcome of transarterial embolization (TAE) plus
octreotide long‐acting repeatable (LAR) on patients with low‐to‐intermediate …

The incidence of liver metastasis in digestive neuroendocrine tumors is high. Their presence
appears as an important prognostic factor in terms of quality of life and survival. These …